SPRUCE BIOSCIENCES INC (SPRB) Stock News

NASDAQ:SPRB - Nasdaq - US85209E1091 - Common Stock - Currency: USD

0.0786 -0.05 (-39.45%)

After market: 0.0788 +0 (+0.25%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

SPRB Latest News, Press Relases and Analysis

All

Press Releases

6 days ago - By: Spruce Biosciences, Inc.

Spruce Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

6 days ago - By: Spruce Biosciences, Inc.

Spruce Biosciences Announces Integrated Long-Term Clinical Data of Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) Demonstrating Profound and Durable Efficacy and Safety in Patients with Sanfilippo Syndrome Type B (MPS IIIB)

13 days ago - By: Zacks Investment Research - Mentions: PBYI

Puma Biotech (PBYI) Surpasses Q2 Earnings and Revenue Estimates

15 days ago - By: Zacks Investment Research - Mentions: CRIS

Curis (CRIS) Reports Q2 Loss, Beats Revenue Estimates

20 days ago - By: Zacks Investment Research - Mentions: ILMN

Illumina (ILMN) Q2 Earnings and Revenues Surpass Estimates

a year ago - By: BusinessInsider

News Image

SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q2 2024

a month ago - By: Spruce Biosciences, Inc.

Spruce Biosciences Announces Reverse Stock Split

a month ago - By: HMNC Holding GmbH

HMNC Brain Health and Spruce Biosciences Announce First Patient Dosed in Phase 2 TAMARIND Trial For Major Depressive Disorder

2 months ago - By: Spruce Biosciences, Inc. - Mentions: OTC

Spruce Biosciences Announces Conditional Nasdaq Approval to Resume Trading on the Nasdaq Capital Market

4 months ago - By: Spruce Biosciences, Inc. - Mentions: OTC

Spruce Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Updates

4 months ago - By: Benzinga - Mentions: BCLI IBIO ABP HCTI ...

12 Health Care Stocks Moving In Monday's Intraday Session

4 months ago - By: Benzinga - Mentions: PLUG ROP GRPN GLMD ...

Crude Oil Down 2%; Roper Technologies Increases 2025 Outlook

4 months ago - By: Spruce Biosciences, Inc.

Spruce Biosciences Announces New Corporate Strategy and Acquisition of Tralesinidase Alfa for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)

8 months ago - By: Yahoo Finance

Penny Stock Spruce Biosciences Winds Down Tildacerfont Studies For Rare Genetic Disorder

8 months ago - By: Spruce Biosciences, Inc.

Spruce Biosciences Announces Topline Results from CAHmelia-204 in Adult CAH and CAHptain-205 in Adult and Pediatric CAH

9 months ago - By: Spruce Biosciences, Inc.

Spruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

10 months ago - By: Spruce Biosciences, Inc.

Spruce Biosciences to Participate in the Guggenheim Securities Healthcare Innovation Conference

a year ago - By: Spruce Biosciences, Inc.

Spruce Biosciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

a year ago - By: InvestorPlace

SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q2 2024

a year ago - By: Spruce Biosciences, Inc.

Spruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates